Step 1: Select the episodes & 1-minute challenges you'd like to consume
Step 2: Bank time as you blaze your way through the program
Step 3: Claim credit once available as shown in the Progress Bar
Step 4: Track the status of credits claimed in your profile
To experience MinuteCE for yourself, select one of the episodes below to start learning!
The Role of Chemotherapy and Immunotherapy in ROS1-Rearranged NSCLC
The Role of Chemotherapy and Immunotherapy in ROS1-Rearranged NSCLC
Case: Treatment Selection for ROS1-Rearranged NSCLC Patient with Brain Metastases
Case: Treatment Selection for ROS1-Rearranged NSCLC Patient with Brain Metastases
Safety and Tolerability of ROS1 Tyrosine Kinase Inhibitors
Safety and Tolerability of ROS1 Tyrosine Kinase Inhibitors
Later-Line Targeted Therapies for ROS1 Fusion-Positive Lung Cancers
Later-Line Targeted Therapies for ROS1 Fusion-Positive Lung Cancers
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
Overcoming Acquired TKI-Resistance with Next-generation ROS1-TKI Agents
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive Patient
Treatment Strategy of ROS1-Rearranged NSCLC in TKI-Naive Patient
First-Line Targeted Therapies for ROS1 Fusion-Positive Lung Cancers
First-Line Targeted Therapies for ROS1 Fusion-Positive Lung Cancers
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?